Articles

May 13, 2008
EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions
Costa Júnior J, Abizaid A, Feres F, Costa R, Seixas A, Maia F, Abizaid An, Tanajura L, Staico R, Siqueira D, Meredith L, Bhat V, Yan J, Ormiston J, Sousa A, Fitzgerald P, Sousa J
free

May 13, 2008
Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results
Grube E, Sievert H, Hauptmann K-E, Mueller R, Gerckens U, Buellesfeld L, Ako J, Shimohama T, Costa M, Fitzgerald P
free

May 13, 2008
Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)
Meliga E, Garcia-Garcia H, Valgimigli M, Chieffo A, Biondi-Zoccai G, O’ Maree A, Gonzalo N, Cook S, Cruz-González I, Marra S, De Servi S, Palacios I, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys PW
free

May 13, 2008
European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions.
Sianos G, Barlis P, Di Mario C, Papafaklis M, Büttner J, Galassi A, Schofer J, Werner G, Lefèvre T, Louvard Y, Serruys PW, Reifart N
free

May 13, 2008
Impact of bifurcation lesions on clinical outcome and prognosis of primary angioplasty in acute myocardial infarction
Abdel Hakim D-E, Garot P, Champagne S, Maklady F, El Hawary A, Dubois-Randé J-L, Lesault P-F, Teiger E
free

May 13, 2008
Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions
Assali A, Raz Y, Vaknin-Assa H, Ben-Dor I, Brosh D, Teplitsky I, Fuchs S, Kornowski R
free

May 13, 2008
Lower levels of in-stent late loss are not associated with the risk of stent thrombosis in patients receiving drug-eluting stents
Rivero F, Moreno R, Barreales L, Galeote G, Sanchez Recalde A, Calvo L, Jiménez-Valero S, Villate A, Vanegas M, López-Sendón J-L
free

May 13, 2008
Percutaneous aortic valve implantation utilising a novel tissue valve: preclinical experience
Bolling S, Rogers J, Babaliaros V, Piazza N, Takeda P, Low R, Block P
free
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved